As previous studies reported, RAS pathway mutations were well-known recurrent somatic variants in pediatric BCP-ALL, and the vast majority of mutations occurred in KRAS, NRAS, PTPN11, FLT3, and NF1 [26,27]. The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.